Connaughton Bernadette, Director at HALOZYME THERAPEUTICS, INC., sold $167K of HALO
This page documents an SEC Form 4 insider trading disclosure for $HALO securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.
Transaction Details
| Insider | Connaughton Bernadette |
|---|---|
| Title | Director |
| Company | HALOZYME THERAPEUTICS, INC. |
| Ticker | HALO |
| Transaction Type | Sale |
| Transaction Date | 2026-08-10 |
| Shares Traded | 1,626 |
| Price Per Share | $102.8 |
| Total Value | $167K |
| Filed Date | 2026-08-11 |
| Accession Number | 0001662521-26-000002 |
Ownership Context
| Shares Owned After Transaction | 40,418 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001662521-26-000002
Other Insider Trades — HALO
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Torley Helen | PRESIDENT AND CEO, Director | traded | $23K | 2026-07-08 |
| Torley Helen | PRESIDENT AND CEO, Director | sold | $83K | 2026-07-08 |
| Torley Helen | PRESIDENT AND CEO, Director | sold | $70K | 2026-07-08 |
| Connaughton Bernadette | Director | sold | $76K | 2026-07-01 |
| Snellgrove Darren | SVP, Chief Financial Officer | traded | — | 2026-07-01 |
| Snellgrove Darren | SVP, Chief Financial Officer | traded | — | 2026-07-01 |
| RAMSAY DAVID A | EVP, PRESIDENT, DRUG DELIVERY | traded | — | 2026-07-01 |
| RAMSAY DAVID A | EVP, PRESIDENT, DRUG DELIVERY | traded | — | 2026-07-01 |
| Connaughton Bernadette | Director | sold | $48K | 2026-07-01 |
| RAMSAY DAVID A | EVP, PRESIDENT, DRUG DELIVERY | traded | — | 2026-06-30 |
Other Trades by Connaughton Bernadette
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | sold | $48K | 2026-07-01 |
| HALO | HALOZYME THERAPEUTICS, INC. | sold | $76K | 2026-07-01 |
| EDIT | Editas Medicine, Inc. | traded | — | 2026-06-17 |
| HALO | HALOZYME THERAPEUTICS, INC. | sold | $108K | 2026-06-01 |
| HALO | HALOZYME THERAPEUTICS, INC. | traded | — | 2026-05-05 |
| HALO | HALOZYME THERAPEUTICS, INC. | traded | — | 2026-05-05 |
| HALO | HALOZYME THERAPEUTICS, INC. | sold | $103K | 2026-05-01 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for HALO — HALOZYME THERAPEUTICS, INC. →
Whisper Score — HALO
Track HALO insider activity in real time on The Wire →
Get alerts when Connaughton Bernadette files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: August 12, 2026 at 07:00 UTC